Skip to main content
OpenTrials
Completed

NCT Number: NCT00000214

IV Cocaine Abuse: A Laboratory Model - 3

The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Columbia University

New York, 10023, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

buprenorphine

Drug

Primary outcomes

  1. Direct cocaine effects (caridio, subjective)

  2. Interaction of coc/bup on cardio measures

  3. Ineraction of coc/bup on coc's subjective effects

  4. Effects of buprenorphine on cocaine craving

Sponsors and collaborators

Lead sponsor

New York State Psychiatric Institute

Other

Collaborators

  • Columbia University
  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

IV Cocaine Abuse: A Laboratory Model

Important dates

Study start
1992
Primary completion
1993
Study completion
1993
First posted
Sep 21, 1999
Registry last updated
Aug 31, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.